Literature DB >> 19082788

Radiation therapy in urinary cancer: state of the art and perspective.

M Troiano1, P Corsa, A Raguso, S Cossa, M Piombino, G Guglielmi, S Parisi.   

Abstract

Invasive urinary tumours are relatively rare, and their treatment may cause important changes in urinary, sexual and social functions. A systematic review of external radiation therapy studies in urinary cancers was performed. This synthesis of the literature is based on data from meta-analyses, randomised and prospective trials and retrospective studies. There are few controlled clinical trials using adjuvant or radical radiotherapy with or without chemotherapy in cancer of the kidney, ureter and urethra. There are several reports on multimodality treatment in invasive bladder cancer: intravesical surgery and neoadjuvant chemotherapy to radiotherapy or concomitant radiochemotherapy with organ preservation. The conclusions reached for renal cancer are controversial, and data on cancers of the urethra and ureter are few and inconclusive. Sufficient data now exist in the literature to demonstrate that conservative management with organ preservation is a valuable alternative to radical cystectomy, the traditional gold standard, in invasive bladder cancer.

Entities:  

Mesh:

Year:  2008        PMID: 19082788     DOI: 10.1007/s11547-008-0347-5

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  77 in total

1.  Planned preoperative radiation therapy in muscle invasive bladder cancer; results of a meta-analysis.

Authors:  M Huncharek; J Muscat; J F Geschwind
Journal:  Anticancer Res       Date:  1998 May-Jun       Impact factor: 2.480

2.  Is post-operative radiation for renal cell carcinoma justified?

Authors:  I Aref; R G Bociek; D Salhani
Journal:  Radiother Oncol       Date:  1997-05       Impact factor: 6.280

3.  Postoperative radiotherapy of carcinoma in bilharzial bladder: improved disease free survival through improving local control.

Authors:  M S Zaghloul; H K Awwad; H H Akoush; S Omar; O Soliman; I el Attar
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

4.  The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response.

Authors:  D S Kaufman; K A Winter; W U Shipley; N M Heney; M P Chetner; L Souhami; R A Zlotecki; W T Sause; L D True
Journal:  Oncologist       Date:  2000

5.  Urethral carcinoma in women: results of treatment with primary radiotherapy.

Authors:  M F Milosevic; P R Warde; D Banerjee; M K Gospodarowicz; M McLean; P A Catton; C N Catton
Journal:  Radiother Oncol       Date:  2000-07       Impact factor: 6.280

6.  Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer.

Authors:  R Sauer; S Birkenhake; R Kühn; C Wittekind; K M Schrott; P Martus
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-01-01       Impact factor: 7.038

7.  Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.

Authors:  Donatella Tirindelli Danesi; Giorgio Arcangeli; Enrico Cruciani; Pierluigi Altavista; Antonella Mecozzi; Bianca Saracino; Filina Orefici
Journal:  Cancer       Date:  2004-12-01       Impact factor: 6.860

8.  Alternating chemo-radiotherapy in bladder cancer: a conservative approach.

Authors:  M Orsatti; A Curotto; L Canobbio; D Guarneri; D Scarpati; M Venturini; P Franzone; S Giudici; G Martorana; F Boccardo
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-08-30       Impact factor: 7.038

9.  Retrospective study of the treatment of urethral cancer.

Authors:  Tony Y Eng; Marco Naguib; Timothy Galang; Clifton D Fuller
Journal:  Am J Clin Oncol       Date:  2003-12       Impact factor: 2.339

10.  Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patients.

Authors:  A Pollack; G K Zagars; C P Dinney; D A Swanson; A C von Eschenbach
Journal:  Cancer       Date:  1994-11-15       Impact factor: 6.860

View more
  2 in total

1.  Intraluminal urethral brachytherapy for recurrence of transitional cell carcinoma of urinary bladder in urethral stump.

Authors:  Bikramjit Chakrabarti; Suman Ghorai; Somapriya Basu Ray; Sanjay Kumar Kar
Journal:  J Contemp Brachytherapy       Date:  2013-03-29

2.  Adenocarcinoma of the female urethra: Clear-cell variant.

Authors:  Jordan Caplan; Matthew Hartman; Gina Rooker
Journal:  Radiol Case Rep       Date:  2015-11-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.